AT
BSX icon

Arlington Trust’s Boston Scientific BSX Stock Holding History

Arlington Trust’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.28K Sell
194
-830
-81% -$45.1K ﹤0.01% 496
2026
Q1 		$64.3K Buy
1,024
+61
+6% +$4.88K 0.01% 202
2025
Q4 		$91.8K Sell
963
-17
-2% -$1.67K 0.01% 145
2025
Q3 		$95.7K Hold
980
– – 0.02% 273
2025
Q2 		$105K Buy
980
+20
+2% +$2.02K 0.02% 255
2025
Q1 		$96.8K Buy
960
+830
+638% +$83.6K 0.02% 266
2024
Q4 		$11.6K Hold
130
– – ﹤0.01% 457
2024
Q3 		$10.9K Buy
+130
New +$10.2K ﹤0.01% 444
2024
Q1 		– Sell
-57
Closed -$3.29K – 539
2023
Q4 		$3.29K Buy
+57
New +$3.04K ﹤0.01% 531

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Arlington Trust's BSX Position: Q2 2026 in Review

Arlington Trust reduced its Boston Scientific (BSX) stake by 81% in Q2 2026, selling an estimated $45.1K and leaving 194 shares worth $8.28K. The position accounts for ﹤0.01% of the portfolio, ranked #496.

Arlington Trust first reported a position in BSX in Q4 2023 and has held it in 9 quarters since. The position peaked at $105K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Arlington Trust held 194 shares of Boston Scientific worth $8.28K as of Q2 2026.
  • Arlington Trust sold 830 Boston Scientific shares in Q2 2026, an estimated $45.1K.
  • Boston Scientific made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #496 holding.
  • Arlington Trust first reported a position in Boston Scientific in Q4 2023 and has held it in 9 quarters since.
  • Arlington Trust's Boston Scientific position peaked at $105K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.